netFormulary NHS
Nottinghamshire Area Prescribing Committee
Joint Formulary
 Search
 Formulary Chapter 12: Ear, nose and oropharynx - Full Chapter
12.03.02  Expand sub section  Oropharyngeal anti-infective drugs
12.03.02  Expand sub section  Oropharyngeal Fungal infections
Miconazole (Daktarin)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Oral gel

  • See link for interactions of miconazole.
  • OTC Patients should be advised to purchase a suitable product over the counter first line

 
Link  MHRA 2016: Reminder of potential for serious interactions with warfarin
Link  SFH guide to mouthcare products
Link  UKMI Q&A: Can miconazole oral gel be used by patients taking a statin?
   
Nystatin
View adult BNF View SPC online View childrens BNF
Formulary
Green

Oral suspension 100,000 units per mL

  • Clarification from the BNF (March 2017) has confirmed that the dose should be 100,000 units (1ml) FOUR times daily.
  • As per CKS guidance usually use miconazole gel or oral fluconazole instead unless contraindicated or important interaction.)
  • OTC Patients should be advised to purchase a suitable product over the counter first line

 
Link  SFH guide to mouthcare products
   
12.03.02  Expand sub section  Oropharyngeal Viral infections
 ....
 Non Formulary Items
Amphotericin Lozenges  (Fungilin)

View adult BNF View SPC online View childrens BNF
Non Formulary
Grey
Discontinued in the UK.
 
Miconazole  (Loramyc)

View adult BNF View SPC online View childrens BNF
Non Formulary
Grey
Mucoadhesive buccal tablets
  • licensed for oropharyngeal candidiasis in immunocompromised
  • Link  Link to reviews
     
      
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    SMC
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Grey

    Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.
    Grey / Non-Formulary (undergoing assessment): Work is ongoing and will be reviewed at a future APC meeting.
    Grey / Non-Formulary (no formal assessment): APC has not formally reviewed this medicine or indication because it had never been requested for formulary inclusion. Often used for drugs new to market.
      

    Red

    Medicines which should normally be prescribed by specialists only. eg hospital only.
    For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.
      

    Amber 1

    Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised.
    Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the Nottinghamshire APC.
      

    Amber 2

    Medicines suitable to be prescribed in primary care / general practice after specialist* recommendation or initiation.
    A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust DTCs and approved by the Nottinghamshire APC.
    *Specialist is defined by the APC as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice
      

    Amber 3

    Primary care/ non specialist may initiate as per APC guideline.
    The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC.
      

    Green

    Medicines suitable for routine use within primary care.
    Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.   

    OTC

      

    netFormulary